Annual Shareholders Equity
-$5.05 M
-$16.16 M-145.42%
31 December 2023
Summary:
Dare Bioscience annual stockholders equity is currently -$5.05 million, with the most recent change of -$16.16 million (-145.42%) on 31 December 2023. During the last 3 years, it has fallen by -$3.90 million (-338.27%). DARE annual shareholders equity is now -110.36% below its all-time high of $48.74 million, reached on 31 December 2015.DARE Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
-$1.48 M
-$4.16 M-155.57%
30 September 2024
Summary:
Dare Bioscience quarterly stockholders equity is currently -$1.48 million, with the most recent change of -$4.16 million (-155.57%) on 30 September 2024. Over the past year, it has increased by +$804.20 thousand (+35.14%). DARE quarterly shareholders equity is now -102.18% below its all-time high of $68.20 million, reached on 30 June 2015.DARE Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DARE Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -145.4% | +35.1% |
| 3 y3 years | -338.3% | -104.7% |
| 5 y5 years | -175.0% | -182.0% |
DARE Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -113.0% | at low | -103.8% | +86.5% |
| 5 y | 5 years | -113.0% | at low | -103.8% | +86.5% |
| alltime | all time | -110.4% | +94.7% | -102.2% | +98.5% |
Dare Bioscience Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$1.48 M(-155.6%) |
| June 2024 | - | $2.67 M(-124.3%) |
| Mar 2024 | - | -$11.00 M(+117.9%) |
| Dec 2023 | -$5.05 M(-145.4%) | -$5.05 M(+120.5%) |
| Sept 2023 | - | -$2.29 M(-15.8%) |
| June 2023 | - | -$2.72 M(-154.7%) |
| Mar 2023 | - | $4.97 M(-55.3%) |
| Dec 2022 | $11.11 M(-71.3%) | $11.11 M(-57.8%) |
| Sept 2022 | - | $26.34 M(-20.3%) |
| June 2022 | - | $33.03 M(+7.0%) |
| Mar 2022 | - | $30.88 M(-20.3%) |
| Dec 2021 | $38.75 M(-3465.0%) | $38.75 M(+21.5%) |
| Sept 2021 | - | $31.89 M(+311.8%) |
| June 2021 | - | $7.74 M(+137.7%) |
| Mar 2021 | - | $3.26 M(-382.9%) |
| Dec 2020 | -$1.15 M(-361.3%) | -$1.15 M(-16.9%) |
| Sept 2020 | - | -$1.39 M(-545.2%) |
| June 2020 | - | $311.30 K(-90.3%) |
| Mar 2020 | - | $3.21 M(+629.2%) |
| Dec 2019 | $440.80 K | $440.80 K(-75.6%) |
| Sept 2019 | - | $1.81 M(-64.4%) |
| June 2019 | - | $5.08 M(+34.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $3.78 M(-43.8%) |
| Dec 2018 | $6.73 M(-49.4%) | $6.73 M(-29.8%) |
| Sept 2018 | - | $9.58 M(-21.6%) |
| June 2018 | - | $12.22 M(-22.8%) |
| Mar 2018 | - | $15.82 M(+19.0%) |
| Dec 2017 | $13.29 M(-1970.6%) | $13.29 M(-40.7%) |
| Sept 2017 | - | $22.43 M(+452.5%) |
| June 2017 | - | $4.06 M(-47.6%) |
| Mar 2017 | - | $7.74 M(-1189.4%) |
| Dec 2016 | -$710.60 K(-101.5%) | -$710.60 K(-104.3%) |
| Sept 2016 | - | $16.62 M(-35.7%) |
| June 2016 | - | $25.84 M(-28.2%) |
| Mar 2016 | - | $35.98 M(-26.2%) |
| Dec 2015 | $48.74 M(+7.5%) | $48.74 M(-16.9%) |
| Sept 2015 | - | $58.64 M(-14.0%) |
| June 2015 | - | $68.20 M(+68.8%) |
| Mar 2015 | - | $40.41 M(-10.8%) |
| Dec 2014 | $45.33 M(-148.1%) | $45.33 M(-13.7%) |
| Sept 2014 | - | $52.53 M(-9.1%) |
| June 2014 | - | $57.81 M(-159.6%) |
| Mar 2014 | - | -$97.04 M(+2.9%) |
| Dec 2013 | -$94.30 M(+17.8%) | -$94.30 M |
| Dec 2012 | -$80.04 M | - |
FAQ
- What is Dare Bioscience annual stockholders equity?
- What is the all time high annual shareholders equity for Dare Bioscience?
- What is Dare Bioscience annual shareholders equity year-on-year change?
- What is Dare Bioscience quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Dare Bioscience?
- What is Dare Bioscience quarterly shareholders equity year-on-year change?
What is Dare Bioscience annual stockholders equity?
The current annual shareholders equity of DARE is -$5.05 M
What is the all time high annual shareholders equity for Dare Bioscience?
Dare Bioscience all-time high annual stockholders equity is $48.74 M
What is Dare Bioscience annual shareholders equity year-on-year change?
Over the past year, DARE annual stockholders equity has changed by -$16.16 M (-145.42%)
What is Dare Bioscience quarterly stockholders equity?
The current quarterly shareholders equity of DARE is -$1.48 M
What is the all time high quarterly shareholders equity for Dare Bioscience?
Dare Bioscience all-time high quarterly stockholders equity is $68.20 M
What is Dare Bioscience quarterly shareholders equity year-on-year change?
Over the past year, DARE quarterly stockholders equity has changed by +$804.20 K (+35.14%)